Results 221 to 230 of about 62,672 (281)

Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 5, May 2026.
ABSTRACT Aim Adverse events (AEs) detected in tweets and in the FDA Adverse Event Reporting System (FAERS) provide valuable insights into patient experiences with oral hypoglycemic agents including sodium‐glucose transporter 2 (SGLT2) and dipeptidyl peptidase‐4 (DPP4) inhibitors. This study compared the side effects identified from tweets with those in
Se‐Hoon Oh, Dong‐Young Park, Yun‐Kyoung Song   +2 more
wiley   +1 more source

The critical role of pharmacovigilance in monitoring drug-induced QT prolongation. [PDF]

Indian J Med Res
James J.
europepmc   +1 more source

Methods of Suicide Used by People With Cancer: A Scoping Review

Psycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Background Individuals diagnosed with cancer are at increased risk of suicide compared to the general population. Access to means is a key volitional risk factor for suicide and represents a modifiable target for prevention at a population level.
Doireann Ni Dhalaigh, Zubair Kabir, Fahmi Ismail, Paul Corcoran, Daisy Wiggin, Eugene Cassidy   +5 more
wiley   +1 more source

Knowledge, attitude, and practice of pharmacovigilance among healthcare professionals at a tertiary level hospital, Sudan: a cross sectional study. [PDF]

BMC Health Serv Res
Hamid M, Osman M.
europepmc   +1 more source

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos   +51 more
wiley   +1 more source

Impact of combined oral contraceptives and progestin‐only pills on psychological and sexual well‐being of women with endometriosis: A systematic review

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 805-818, May 2026.
Hormonal treatments for endometriosis (combined oral contraceptives/progestin‐only pills) do not show increased psychological or sexual risks compared with placebo. When pain is effectively controlled, these therapies appear well tolerated and may improve overall well‐being.
Noemi Salmeri, Martina Piccini, Francesca Caprara, Edgardo Somigliana, Paola Viganò, Paolo Vercellini   +5 more
wiley   +1 more source

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]

BMC Infect Dis
Etuk VP, Adeoye IA, Salawu MM, Fawole OI.   +3 more
europepmc   +1 more source

Fostering deliberation and action in context: An analysis of implementation research among healthcare professionals in LMICs from a post‐digital perspective

British Journal of Educational Technology, Volume 57, Issue 3, Page 746-774, May 2026.
Abstract Strengthening health systems through workforce development is central to combating health crises and inequalities in some of the world's poorest countries and is a key objective for implementation research (IR). Workforce development programmes often include blended and online modalities, offering the means to reach relevant communities at ...
Koula Charitonos, Allison Littlejohn, Saraswati Dawadi, Abhinav Vaidya, Alex Owusu‐Ofori, Fereshte Goshtasbpour, Santosi Giri   +6 more
wiley   +1 more source

Career pathways for pharmacologists in India: A clinical pharmacologist's perspective.

Indian J Pharmacol
Singh S, Tiwari K.
europepmc   +1 more source

Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis. [PDF]

PLoS One
Shen P, Peng MS, Kim SJ, Joung KI, Kim KJ.   +4 more
europepmc   +1 more source